Caro Holdings Inc. (CAHO) stock: key figures, P/E, revenue and dividend
Consumer Discretionary · United Kingdom
Caro Holdings Inc. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 36,319.00 USD | 11,254.00 USD |
| Operating income | -392,094.00 USD | -282,284.00 USD |
| EBIT | -376,833.00 USD | -273,673.00 USD |
| Net income | -692,956.00 USD | -407,797.00 USD |
| Diluted EPS – continuing operations | -0.02 USD | -0.01 USD |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Caro Holdings Inc.
Caro Holdings Inc. engages in the deployment of B2B, B2C, and D2C systems and methodologies in the United States. It offers B2B, B2C, and D2C solutions, a platform that allows marketing, analytics, and e-commerce functionality around an industry-specific directory niches for small to mid-sized retailers. Caro Holdings Inc. was incorporated in 2016 and is based in Sheffield, the United Kingdom.
More stocks
- Estrella Immunopharma, Inc. (ESLA)
- Transcode Therapeutics, Inc. (RNAZ)
- Helio Corp /FL/ (HLEO)
- GEX MANAGEMENT, INC. (GXXM)
- CHINA PHARMA HOLDINGS, INC. (CPHI)
- Gouverneur Bancorp, Inc./MD/ (GOVB)
- BranchOut Food Inc. (BOF)
- AgEagle Aerial Systems Inc. (UAVS)
- Stran & Company, Inc. (SWAG)
- VIVOS INC (RDGL)
- TherapeuticsMD, Inc. (TXMD)
- Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.